Original Title: Regression of Paravalvular Aortic Regurgitation and Remodeling of Self-Expanding Transcatheter Aortic Valve. An Observation From the CoreValve U.S. Pivotal Trial. Reference: Jae K. Oh et al. J Am Coll Cardiol Img. 2015, online first. The aim of this study was to describe the natural evolution and the clinical significance of paravalvular aortic insufficiency after<a href="https://solaci.org/en/2015/11/20/spontaneous-regression-of-paravalvular-aortic-regurgitation-with-self-expanding-prosthesis/" title="Read more" >...</a>
TAVI in patients older than 90: similar outcomes to those obtained in younger patients
Original title: Comparison of Outcomes of Transcathether Aortic Valve Implantation in Patients ≥90 Years Versus <90 Years. Reference: Yigal Abramowitz, et al. Am J Cardiol 2015;116:1110-1115. More and more 90 year old patients require transcatheter aortic valve replacement (TAVI); however, its benefits have not been studied in this particular population. This study enrolled 734 patients<a href="https://solaci.org/en/2015/11/16/tavi-in-patients-older-than-90-similar-outcomes-to-those-obtained-in-younger-patients/" title="Read more" >...</a>
Artículo de revisión: Células Madre de Tejido Adiposo y la Importancia de la Estandarización de un Modelo Animal para Experimentos Preclínicos
Marilia Sanches Santos Rizzo Zuttion; Cristiane Valverde Wenceslau; Pedro A. Lemos; Celso Takimura; Irina Kerkis
Magazines
JSHD | JOURNAL OF STRUCTURAL HEART DISEASE The scope of the Journal of Structural Heart Disease includes all adults with structural and congenital heart diseases, including imaging related to interventional therapies in structural and congenital heart disease. Principal subjects of the journal include the aortic valve, the aortic arch, the mitral valve, the left atrial<a href="https://solaci.org/en/2015/07/13/magazines/" title="Read more" >...</a>
Bons resultados clínicos após implante transcateter da prótese valvar mitral Edwards Fortis®
Fundamentos: A regurgitação mitral severa (MR) representa a segunda doença cardíaca valvar mais prevalente nos países ocidentais. De um terço a metade dos pacientes que necessitam de reparo da valva mitral / substituição são considerados de muito alto risco para cirurgia. O procedimento percutâneo mitral de reparo de borda a borda surgiu como uma alternativa<a href="https://solaci.org/en/2015/06/24/bons-resultados-clinicos-apos-implante-transcateter-da-protese-valvar-mitral-edwards-fortis-2/" title="Read more" >...</a>
PARTNER II: Less oversizing to reduce paravalvular failure with the new generation of SAPIEN 3
The new generation SAPIEN 3 valve was designed to reduce paravalvular aortic regurgitation. The objective of this work was to evaluate the influence of “oversizing” for SAPIEN 3 valve both in relation to the area and the perimeter and determine if calcium ring influences the degree of failure. A lesser degree of oversizing need it<a href="https://solaci.org/en/2015/06/24/partner-ii-less-oversizing-to-reduce-paravalvular-failure-with-the-new-generation-of-sapien-3/" title="Read more" >...</a>
Bons resultados nos procedimentos de implante transcateter valva-em-valva mitral e valva-em-anel mitral
Fundamentos: Válvulas bioprotéticas são cada vez mais implantadas em cirurgias cardíacas abertas. Estas válvulas geralmente falham, resultando na necessidade de uma nova cirurgia cardíaca, com risco elevado de mortalidade. O implante transcateter valva-em-valva mitral (VIVM) pode eliminar a necessidade de reoperação. A implantação transcateter valva-em-valva e valva-em-anel mitral (VIAM) é uma abordagem menos invasiva e,<a href="https://solaci.org/en/2015/06/24/bons-resultados-nos-procedimentos-de-implante-transcateter-valva-em-valva-mitral-e-valva-em-anel-mitral-2/" title="Read more" >...</a>
SAPIENS 3: Favorable outcomes with TAVI in intermediate risk patients
Transcatheter aortic valve replacement is a safe and effective alternative to surgery in patients with severe aortic stenosis and high surgical risk as the 5-year results of PARTNER 1 Alternate showed. The aim of this study was to evaluate the result of the Edwards Sapien 3 valve in patients with severe aortic stenosis and intermediate<a href="https://solaci.org/en/2015/06/24/sapiens-3-favorable-outcomes-with-tavi-in-intermediate-risk-patients/" title="Read more" >...</a>
TAVR é um procedimento tão seguro e eficaz quanto a substituição cirúrgica num seguimento de dois anos em pacientes de menor risco.
Fundamentos e Objetivos: A substituição da válvula aórtica via transcateter (TAVR) é uma opção em determinados pacientes cirúrgicos de alto risco com estenose da válvula aórtica grave. Desconhecemos se a TAVR pode ser introduzida com segurança para os pacientes de baixo risco. O estudo NOTION (Nordic Aortic Valve Intervention Trial) é um ensaio clínico randomizado<a href="https://solaci.org/en/2015/06/24/tavr-e-um-procedimento-tao-seguro-e-eficaz-quanto-a-substituicao-cirurgica-num-seguimento-de-dois-anos-em-pacientes-de-menor-risco-2/" title="Read more" >...</a>
NOTION: TAVR in low-risk patients
The aim of this study was to compare the results of transcatheter aortic valve replacement (TAVR) versus surgery in unselected patients with severe degenerative aortic stenosis. Patients were randomized 1:1 to TAVR (n = 145) or surgical replacement (n = 135). Those of TAVR group received Medtronic CoreValve self-expanding valve. The femoral access was used<a href="https://solaci.org/en/2015/06/24/notion-tavr-in-low-risk-patients/" title="Read more" >...</a>